🇰🇷 Gilenya in South Korea

Gilenya (FINGOLIMOD) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Gilenya in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in South Korea

Frequently asked questions

Is Gilenya approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Gilenya in South Korea?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.